Clinical trial
Study of Serum Tumor Markers of HBV Associated HCC
NCT05825196 is registered in ClinicalTrials.gov with Qianfoshan Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study of Serum Tumor Markers of HBV Associated HCC
- Lead sponsor
- Qianfoshan Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- May 1, 2023
- Completion date
- December 31, 2025
- Enrollment
- 164 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
hcc